Decoy Therapeutics Inc.(DCOY)

Biotechnology · Houston, TX

$1.66-0.01 (-0.60%)

Delayed quote: Oct 6, 2026, 10:17 AM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T14:21:28.173Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:21:28.173Z.

Quote observation: 2026-10-06T14:17:07.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 1.66
Unrounded diluted TTM EPS · period ending 2026-06-30: -29.0937

FMP input reference: 4d5e19f74cb926d0196b5f3ffb65db8ff8affa0edec331fa5277d4ca2ec73e8d

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

DCOY PE Ratio Metrics

PE RATIO

N/A

DCOY Competitors' PE Ratio

DCOY

Decoy Therapeutics Inc.

Current

Market Cap

$883067.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BBLG

Bone Biologics Corporation

vs DCOY

Market Cap

$874595.00

PE Ratio

N/A

TTM Avg

0.00

3Y Avg

0.00

5Y Avg

0.00

GCTK

GlucoTrack, Inc.

vs DCOY

Market Cap

$893920.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BJDX

Bluejay Diagnostics, Inc.

vs DCOY

Market Cap

$848259.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ASBP

Aspire Biopharma Holdings, Inc.

vs DCOY

Market Cap

$1.02M

PE Ratio

N/A

TTM Avg

173046.93

3Y Avg

281427.36

5Y Avg

281427.36

CMND

Clearmind Medicine Inc.

vs DCOY

Market Cap

$1.08M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDT

CDT Equity Inc.

vs DCOY

Market Cap

$667296.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HKPD

Cellyan Biotechnology Co., Ltd

vs DCOY

Market Cap

$1.11M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JUNS

Jupiter Neurosciences, Inc.

vs DCOY

Market Cap

$1.19M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCWB

HCW Biologics Inc.

vs DCOY

Market Cap

$566655.00

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Decoy Therapeutics Inc. (DCOY)	$883067.00	N/A	N/A	N/A	N/A
Bone Biologics Corporation (BBLG)vs ›	$874595.00	N/A	0.00	0.00	0.00
GlucoTrack, Inc. (GCTK)vs ›	$893920.00	N/A	N/A	N/A	N/A
Bluejay Diagnostics, Inc. (BJDX)vs ›	$848259.00	N/A	N/A	N/A	N/A
Aspire Biopharma Holdings, Inc. (ASBP)vs ›	$1.02M	N/A	173046.93	281427.36	281427.36
Clearmind Medicine Inc. (CMND)vs ›	$1.08M	N/A	N/A	N/A	N/A
CDT Equity Inc. (CDT)vs ›	$667296.00	N/A	N/A	N/A	N/A
Cellyan Biotechnology Co., Ltd (HKPD)vs ›	$1.11M	N/A	N/A	N/A	N/A
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.19M	N/A	N/A	N/A	N/A
HCW Biologics Inc. (HCWB)vs ›	$566655.00	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$1.66

Forward EPS (Est.)

$-8.96

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

DCOY PE Ratio Metrics

DCOY Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics